Literature DB >> 9269001

Chalazion-induced hyperopia as a cause of decreased vision.

C S Santa Cruz1, T Culotta, E J Cohen, C J Rapuano.   

Abstract

This article presents three cases of decreased vision due to acquired hyperopia, which were caused by a chalazion of the upper eyelid. Through manifest refraction and computerized corneal topographic analysis, acquired hyperopia associated with central corneal flattening was revealed. These findings were responsible for the blurred vision that was reversed by chalazion resolution or removal. Although not usually considered a risk factor for refractive disorders other than astigmatism, chalazia of the upper eyelid can present as a decrease in vision associated with reversible central corneal flattening and acquired hyperopia.

Entities:  

Mesh:

Year:  1997        PMID: 9269001

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  6 in total

1.  [Ambiguous unilateral visual impairment with hyperopia].

Authors:  E M Feudner; H Wilhelm
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

2.  Ophthaproblem. Chalazion.

Authors:  S Sharma
Journal:  Can Fam Physician       Date:  1998-06       Impact factor: 3.275

3.  Corneal topographic changes after blepharoptosis surgery in patients with deepening of the upper eyelid sulcus.

Authors:  Ayaka Numata; Tatsuya Yunoki; Mitsuya Otsuka; Atsushi Hayashi
Journal:  Jpn J Ophthalmol       Date:  2021-01-09       Impact factor: 2.447

4.  Refractive changes in diabetic patients during intensive glycaemic control.

Authors:  F Okamoto; H Sone; T Nonoyama; S Hommura
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

5.  Effects of chalazia on corneal astigmatism : Large-sized chalazia in middle upper eyelids compress the cornea and induce the corneal astigmatism.

Authors:  Ki Won Jin; Young Joo Shin; Joon Young Hyon
Journal:  BMC Ophthalmol       Date:  2017-03-31       Impact factor: 2.209

6.  The changes in corneal astigmatism after botulinum toxin-a injection in patients with blepharospasm.

Authors:  Nam Ju Moon; Hyeon Il Lee; Jae Chan Kim
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.